{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:20:23Z","timestamp":1780392023707,"version":"3.54.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004770","name":"Universit\u00e0 degli Studi di Parma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004770","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03370-1","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:21:38Z","timestamp":1772234498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The isolated perfused lung: a bridge between in vitro and in vivo studies of inhaled medicinal products"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0522-8303","authenticated-orcid":false,"given":"Virginia","family":"Patterlini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-1456","authenticated-orcid":false,"given":"Fabio","family":"Sonvico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0922-7134","authenticated-orcid":false,"given":"Alessandro","family":"Fioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-4823","authenticated-orcid":false,"given":"Francesca","family":"Buttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"3370_CR1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2174\/1567201819666220823161318","volume":"20","author":"K Mireskandari","year":"2023","unstructured":"Mireskandari K, Ardakani YH, Moghadam ES, Ketabchi F, Rouini M. Fundamentals and applications of isolated perfused lung (IPL) model in the development of pulmonary drug delivery. Curr Drug Deliv. 2023;20:1425\u201340.","journal-title":"Curr Drug Deliv"},{"key":"3370_CR2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/138920012800166571","volume":"13","author":"AE Cooper","year":"2012","unstructured":"Cooper AE, Ferguson D, Grime K. Optimisation of DMPK by the inhaled route: challenges and approaches. Curr Drug Metab. 2012;13:457\u201373.","journal-title":"Curr Drug Metab"},{"key":"3370_CR3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/17425247.2021.1873271","volume":"18","author":"MG Matera","year":"2021","unstructured":"Matera MG, Calzetta L, Ora J, Rogliani P, Cazzola M. Pharmacokinetic\/pharmacodynamic approaches to drug delivery design for inhalation drugs. Expert Opin Drug Deliv. 2021;18:891\u2013906.","journal-title":"Expert Opin Drug Deliv"},{"key":"3370_CR4","doi-asserted-by":"crossref","first-page":"113862","DOI":"10.1016\/j.addr.2021.113862","volume":"177","author":"MA Selo","year":"2021","unstructured":"Selo MA, Sake JA, Kim K-J, Ehrhardt C. In vitro and ex vivo models in inhalation biopharmaceutical research \u2014 advances, challenges and future perspectives. Adv Drug Deliv Rev. 2021;177:113862.","journal-title":"Adv Drug Deliv Rev"},{"key":"3370_CR5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.addr.2006.07.012","volume":"58","author":"M Sakagami","year":"2006","unstructured":"Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev. 2006;58:1030\u201360.","journal-title":"Adv Drug Deliv Rev"},{"key":"3370_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00441-002-0653-5","volume":"311","author":"S Fuchs","year":"2003","unstructured":"Fuchs S, Hollins A, Laue M, Schaefer U, Roemer K, Gumbleton M, et al. Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C. Cell Tissue Res. 2003;311:31\u201345.","journal-title":"Cell Tissue Res"},{"key":"3370_CR7","doi-asserted-by":"crossref","first-page":"1299033","DOI":"10.3389\/fbioe.2023.1299033","volume":"11","author":"L Zhu","year":"2023","unstructured":"Zhu L, Zhang J, Guo Q, Kuang J, Li D, Wu M, et al. Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review. Front Bioeng Biotechnol. 2023;11:1299033.","journal-title":"Front Bioeng Biotechnol"},{"key":"3370_CR8","doi-asserted-by":"crossref","first-page":"120480","DOI":"10.1016\/j.biomaterials.2020.120480","volume":"267","author":"SY Kim","year":"2021","unstructured":"Kim SY, Mongey R, Wang P, Rothery S, Gaboriau DCA, Hind M, et al. The acid injury and repair (AIR) model: A novel ex-vivo tool to understand lung repair. Biomaterials. 2021;267:120480.","journal-title":"Biomaterials"},{"key":"3370_CR9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2020.07.025","volume":"161","author":"M Sakagami","year":"2020","unstructured":"Sakagami M. In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs. Adv Drug Deliv Rev. 2020;161:63\u201374.","journal-title":"Adv Drug Deliv Rev"},{"key":"3370_CR10","doi-asserted-by":"crossref","first-page":"103930","DOI":"10.1016\/j.jddst.2022.103930","volume":"78","author":"A De","year":"2022","unstructured":"De A, Paul S, Reddy YN, Sharma V, Bhaumik J, Tippavajhala VK. Lung-on-chip: its current and future perspective on pharmaceutical and biomedical applications. J Drug Deliv Sci Technol. 2022;78:103930.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3370_CR11","doi-asserted-by":"crossref","first-page":"581995","DOI":"10.3389\/fbioe.2020.581995","volume":"8","author":"A Cidem","year":"2020","unstructured":"Cidem A, Bradbury P, Traini D, Ong HX. Modifying and integrating in vitro and ex vivo respiratory models for inhalation drug screening. Front Bioeng Biotechnol. 2020;8:581995.","journal-title":"Front Bioeng Biotechnol"},{"key":"3370_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2023.29091.gt","volume":"36","author":"G Taylor","year":"2023","unstructured":"Taylor G. The pharmacokinetics of inhaled drugs. J Aerosol Med Pulm Drug Deliv. 2023;36:281\u20138.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"3370_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2017.11.049","volume":"536","author":"A Guillon","year":"2018","unstructured":"Guillon A, S\u00e9cher T, Dailey LA, Vecellio L, de Monte M, Si-Tahar M, et al. Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics. Int J Pharm. 2018;536:116\u201326.","journal-title":"Int J Pharm"},{"key":"3370_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1208\/s12248-020-00456-x","volume":"22","author":"J Eriksson","year":"2020","unstructured":"Eriksson J, Sj\u00f6gren E, Lennern\u00e4s H, Th\u00f6rn H. Drug absorption parameters obtained using the isolated perfused rat lung model are predictive of rat in vivo lung absorption. AAPS J. 2020;22:71.","journal-title":"AAPS J"},{"key":"3370_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/pharmaceutics12020117","volume":"12","author":"K Rubin","year":"2020","unstructured":"Rubin K, Ewing P, B\u00e4ckstr\u00f6m E, Abrahamsson A, Bonn B, Kamata S, et al. Pulmonary metabolism of substrates for key drug-metabolizing enzymes by human alveolar type II cells, human and rat lung microsomes, and the isolated perfused rat lung model. Pharmaceutics. 2020;12:117.","journal-title":"Pharmaceutics"},{"key":"3370_CR16","doi-asserted-by":"crossref","unstructured":"Tronde A, Bosquillon C, Forbes B. The Isolated Perfused Lung for Drug Absorption Studies. In: Ehrhardt C, Kim KJ, editors. Drug Absorption Studies In Situ, In Vitro and In Silico Models [Internet]. Springer; 2008. pp. 135\u201363. Available from: https:\/\/link.springer.com\/chapter\/10.1007\/978-0-387-74901-3_6","DOI":"10.1007\/978-0-387-74901-3_6"},{"key":"3370_CR17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.transproceed.2010.01.016","volume":"42","author":"PM P\u00eago-Fernandes","year":"2010","unstructured":"P\u00eago-Fernandes PM, Werebe E, Cardoso PFG, Pazetti R, de Oliveira KA, Soares PRO, et al. Experimental model of isolated lung perfusion in rats: first brazilian experience using the IL-2 isolated perfused rat or guinea pig lung system. Transplant Proc. 2010;42:444\u20137.","journal-title":"Transplant Proc"},{"key":"3370_CR18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.trsl.2010.01.001","volume":"155","author":"A Bilali","year":"2010","unstructured":"Bilali A, Kurata S, Ikeda S, Georgieva GS, Zhu C, Tomita M, et al. Lung\u2013lung interaction in isolated perfused unilateral hyperventilated rat lungs. Transl Res. 2010;155:228\u201337.","journal-title":"Transl Res"},{"key":"3370_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1289\/ehp.845635","volume":"56","author":"RW Niemeier","year":"1984","unstructured":"Niemeier RW. The isolated perfused lung. Environ Health Perspect. 1984;56:35\u201341.","journal-title":"Environ Health Perspect"},{"key":"3370_CR20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jps.2600750214","volume":"75","author":"PR Byron","year":"1986","unstructured":"Byron PR, Roberts SRN, Clark AR. An isolated perfused rat lung preparation for the study of aerosolized drug deposition and absorption. J Pharm Sci. 1986;75:168\u201371.","journal-title":"J Pharm Sci"},{"key":"3370_CR21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0003-4975(94)92202-0","volume":"58","author":"B Weksler","year":"1994","unstructured":"Weksler B, Blumberg D, Lenert JT, Ng B, Fong Y, Burt ME. Isolated single-lung perfusion with TNF-\u03b1 in a rat sarcoma lung metastases model. Ann Thorac Surg. 1994;58:328\u201332.","journal-title":"Ann Thorac Surg"},{"key":"3370_CR22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/SHK.0000000000000563","volume":"46","author":"C-F Chian","year":"2016","unstructured":"Chian C-F, Chiang C-H, Chuang C-H, Liu S-L, Tsai C-L. SN50, a cell-permeable inhibitor of nuclear factor-&kgr;B, attenuates ventilator-induced lung injury in an isolated and perfused rat lung model. Shock. 2016;46:194\u2013201.","journal-title":"Shock"},{"key":"3370_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1289\/ehp.845643","volume":"56","author":"RA Rhoades","year":"1984","unstructured":"Rhoades RA. Isolated perfused lung preparation for studying altered gaseous environments. Environ Health Perspect. 1984;56:43.","journal-title":"Environ Health Perspect"},{"key":"3370_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08958370490258381","volume":"16","author":"P Gerde","year":"2004","unstructured":"Gerde P, Ewing P, L\u00e5stbom L, Ryrfeldt \u00c5, Waher J, Lid\u00e9n G. A novel method to aerosolize powder for short inhalation exposures at high concentrations: isolated rat lungs exposed to respirable diesel soot. Inhal Toxicol. 2004;16:45\u201352.","journal-title":"Inhal Toxicol"},{"key":"3370_CR25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fmed.2016.00070","volume":"3","author":"K Hals\u00f8y","year":"2016","unstructured":"Hals\u00f8y K, Kondratiev T, Tveita T, Bjertnaes LJ. Effects of constant flow vs. constant pressure perfusion on fluid filtration in severe hypothermic isolated blood-perfused rat lungs. Front Med. 2016;3:70.","journal-title":"Front Med"},{"key":"3370_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02233794","volume":"16","author":"HD Ritchie","year":"1971","unstructured":"Ritchie HD, Hardcastle JD, Hermon-Taylor J, Maclean ADW. Isolated organ perfusion for physiologic studies. Am J Dig Dis. 1971;16:81\u20137.","journal-title":"Am J Dig Dis"},{"key":"3370_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2017.11.013","volume":"124","author":"J Eriksson","year":"2018","unstructured":"Eriksson J, Sj\u00f6gren E, Th\u00f6rn H, Rubin K, B\u00e4ckman P, Lennern\u00e4s H. Pulmonary absorption \u2013 estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis. Eur J Pharm Biopharm. 2018;124:1\u201312.","journal-title":"Eur J Pharm Biopharm"},{"key":"3370_CR28","doi-asserted-by":"crossref","first-page":"1245618","DOI":"10.3389\/fcvm.2023.1245618","volume":"10","author":"L Radomsky","year":"2023","unstructured":"Radomsky L, Koch A, Olbertz C, Liu Y, Beushausen K, Keil J, et al. Composition of ex vivo perfusion solutions and kinetics define differential cytokine\/chemokine secretion in a porcine cardiac arrest model of lung preservation. Front Cardiovasc Med. 2023;10:1245618.","journal-title":"Front Cardiovasc Med"},{"key":"3370_CR29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2020.05.012","volume":"158","author":"AA Gabizon","year":"2020","unstructured":"Gabizon AA, Rosales RTMde, La-Beck NM. Translational considerations in nanomedicine: the oncology perspective. Adv Drug Deliv Rev. 2020;158:140\u201357.","journal-title":"Adv Drug Deliv Rev"},{"key":"3370_CR30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4285\/ctr.23.0057","volume":"38","author":"M Menander","year":"2024","unstructured":"Menander M, Attawar S, Mahesh B, Tisekar O, Mohandas A. Ex vivo lung perfusion and the Organ Care System: a review. Clin Transplant Res. 2024;38:23\u201336.","journal-title":"Clin Transplant Res"},{"key":"3370_CR31","first-page":"611","volume":"65","author":"KG Dritsas","year":"1969","unstructured":"Dritsas KG, Brown D, Couves CM. Perfusion-ventilation of the isolated canine lung: hemodynamic considerations. Surgery. 1969;65:611\u20136.","journal-title":"Surgery"},{"key":"3370_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/1056-8719(94)00069-G","volume":"33","author":"S Uhlig","year":"1995","unstructured":"Uhlig S, Heiny O. Measuring the weight of the isolated perfused rat lung during negative pressure ventilation. J Pharmacol Toxicol Methods. 1995;33:147\u201352.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"3370_CR33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","volume":"56","author":"NR Labiris","year":"2003","unstructured":"Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56:588\u201399.","journal-title":"Br J Clin Pharmacol"},{"key":"3370_CR34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13054-017-1844-5","volume":"21","author":"J Dugernier","year":"2017","unstructured":"Dugernier J, Ehrmann S, Sottiaux T, Roeseler J, Wittebole X, Dugernier T, et al. Aerosol delivery during invasive mechanical ventilation: a systematic review. Crit Care. 2017;21:264.","journal-title":"Crit Care"},{"key":"3370_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0013-9351(76)90107-9","volume":"11","author":"JD Brain","year":"1976","unstructured":"Brain JD, Knudson DE, Sorokin SP, Davis MA. Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ Res. 1976;11:13\u201333.","journal-title":"Environ Res"},{"key":"3370_CR36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/etc.5620010306","volume":"1","author":"HM Mehendale","year":"1982","unstructured":"Mehendale HM. Use of isolated perfused lung in determining pulmonary disposition and potential toxicological significance of inhaled environmental pollutants. Environ Toxicol Chem. 1982;1:231\u201344.","journal-title":"Environ Toxicol Chem"},{"key":"3370_CR37","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/jps.2600711121","volume":"71","author":"RK Brazzell","year":"1982","unstructured":"Brazzell RK, Smith RB, Kostenbauder HB. Isolated perfused rabbit lung as a model for intravascular and intrabronchial administration of bronchodilator drugs I: isoproterenol. J Pharm Sci. 1982;71:1268\u201374.","journal-title":"J Pharm Sci"},{"key":"3370_CR38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pupt.2009.09.004","volume":"23","author":"P Ewing","year":"2010","unstructured":"Ewing P, Ryrfeldt \u00c5, Sj\u00f6berg C-O, Andersson P, Edsb\u00e4cker S, Gerde P. Vasoconstriction after inhalation of budesonide: a study in the isolated and perfused rat lung. Pulm Pharmacol Ther. 2010;23:9\u201314.","journal-title":"Pulm Pharmacol Ther"},{"key":"3370_CR39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/SHK.0b013e31825a1982","volume":"38","author":"C-F Chian","year":"2012","unstructured":"Chian C-F, Chiang C-H, Yuan-Jung C, Chuang C-H, Liu S-L, Yi-Han J, et al. Apocynin attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model. Shock. 2012;38:196\u2013202.","journal-title":"Shock"},{"key":"3370_CR40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/08958378.2023.2289018","volume":"35","author":"AR Nosratabadi","year":"2023","unstructured":"Nosratabadi AR, Gustafsson M, Lov\u00e9n K, Ljunggren SA, Olofsson U, Abbasi S, et al. Airway contraction and cytokine release in isolated rat lungs induced by wear particles from the road and tire interface and road vehicle brakes. Inhal Toxicol. 2023;35:309\u201323.","journal-title":"Inhal Toxicol"},{"key":"3370_CR41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0163-7258(90)90049-8","volume":"47","author":"JM Patel","year":"1990","unstructured":"Patel JM. Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacol Ther. 1990;47:137\u201346.","journal-title":"Pharmacol Ther"},{"key":"3370_CR42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/jamp.2007.0654","volume":"21","author":"P Ewing","year":"2008","unstructured":"Ewing P, Eirefelt SJ, Andersson P, Blomgren A, Ryrfeldt \u00c5, Gerde P. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline. J Aerosol Med Pulm Drug Deliv. 2008;21:169\u201380.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"3370_CR43","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1007\/s11095-017-2251-y","volume":"34","author":"C Bosquillon","year":"2017","unstructured":"Bosquillon C, Madlova M, Patel N, Clear N, Forbes B. A comparison of drug transport in pulmonary absorption models: isolated perfused rat lungs, respiratory epithelial cell lines and primary cell culture. Pharm Res. 2017;34:2532\u201340.","journal-title":"Pharm Res"},{"key":"3370_CR44","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0090-9556(24)15033-7","volume":"27","author":"J Rosenborg","year":"1999","unstructured":"Rosenborg J, Larsson P, Tegn\u00e9r K, Hallstr\u00f6m G. Mass balance and metabolism of [(3)H]formoterol in healthy men after combined i.v. and oral administration-mimicking inhalation. Drug Metab Dispos. 1999;27:1104\u201316.","journal-title":"Drug Metab Dispos"},{"key":"3370_CR45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00003088-200140060-00004","volume":"40","author":"R Donnelly","year":"2001","unstructured":"Donnelly R, Seale JP. Clinical pharmacokinetics of inhaled budesonide. Clin Pharmacokinet. 2001;40:427\u201340.","journal-title":"Clin Pharmacokinet"},{"key":"3370_CR46","first-page":"93","volume":"134","author":"K Tegn\u00e9r","year":"1984","unstructured":"Tegn\u00e9r K, Nilsson HT, Persson CG, Persson K, Ryrfeldt A. Elimination pathways of terbutaline. Eur J Respir Dis Suppl. 1984;134:93\u2013100.","journal-title":"Eur J Respir Dis Suppl"},{"key":"3370_CR47","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/acs.molpharmaceut.9b00289","volume":"16","author":"J Eriksson","year":"2019","unstructured":"Eriksson J, Th\u00f6rn H, Sj\u00f6gren E, Holmst\u00e9n L, Rubin K, Lennern\u00e4s H. Pulmonary dissolution of poorly soluble compounds studied in an ex vivo rat lung model. Mol Pharm. 2019;16:3053\u201364.","journal-title":"Mol Pharm"},{"key":"3370_CR48","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41598-020-79434-4","volume":"11","author":"N C\u00e1rdenes","year":"2021","unstructured":"C\u00e1rdenes N, Sembrat J, Noda K, Lovelace T, \u00c1lvarez D, Bittar HET, et al. Human ex vivo lung perfusion: a novel model to study human lung diseases. Sci Rep. 2021;11:490.","journal-title":"Sci Rep"},{"key":"3370_CR49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2015.04.031","volume":"488","author":"N Gupta","year":"2015","unstructured":"Gupta N, Al-Saikhan FI, Patel B, Rashid J, Ahsan F. Fasudil and SOD packaged in peptide-studded-liposomes: properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs. Int J Pharm. 2015;488:33\u201343.","journal-title":"Int J Pharm"},{"key":"3370_CR50","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jtcvs.2023.08.047","volume":"167","author":"Q Gao","year":"2024","unstructured":"Gao Q, Kahan R, Gonzalez TJ, Zhang M, Alderete IS, DeLaura I, et al. Gene delivery followed by ex vivo lung perfusion using an adeno-associated viral vector in a rodent lung transplant model. J Thorac Cardiovasc Surg. 2024;167:e131\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3370_CR51","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/jphp.12434","volume":"67","author":"AC Dalla-Bona","year":"2015","unstructured":"Dalla-Bona AC, Stoisiek K, Oesterheld N, Schmehl T, Gessler T, Seeger W, et al. Characterization of lung-delivered in-situ forming controlled release formulations. J Pharm Pharmacol. 2015;67:1349\u201354.","journal-title":"J Pharm Pharmacol"},{"key":"3370_CR52","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejpb.2012.04.022","volume":"81","author":"M Dong","year":"2012","unstructured":"Dong M, M\u00fcrdter TE, Philippi C, Loretz B, Schaefer UF, Lehr C-M, et al. Pulmonary delivery and tissue distribution of aerosolized antisense 2\u2032-O-Methyl RNA containing nanoplexes in the isolated perfused and ventilated rat lung. Eur J Pharm Biopharm. 2012;81:478\u201385.","journal-title":"Eur J Pharm Biopharm"},{"key":"3370_CR53","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1165\/rcmb.2006-0234OC","volume":"36","author":"F Blank","year":"2007","unstructured":"Blank F, Rothen-Rutishauser B, Gehr P. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol. 2007;36:669\u201377.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3370_CR54","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.xphs.2017.04.011","volume":"106","author":"C Ehrhardt","year":"2017","unstructured":"Ehrhardt C, B\u00e4ckman P, Couet W, Edwards C, Forbes B, Frid\u00e9n M, et al. Current progress toward a better understanding of drug disposition within the lungs: summary proceedings of the first workshop on drug transporters in the lungs. J Pharm Sci. 2017;106:2234\u201344.","journal-title":"J Pharm Sci"},{"key":"3370_CR55","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1002\/jps.23587","volume":"102","author":"G Al-Jayyoussi","year":"2013","unstructured":"Al-Jayyoussi G, Price DF, Francombe D, Taylor G, Smith MW, Morris C, et al. Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: A study in ex vivo lung models using chemical inhibition and genetic knockout. J Pharm Sci. 2013;102:3382\u201394.","journal-title":"J Pharm Sci"},{"key":"3370_CR56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00001813-200307000-00004","volume":"14","author":"O Kuhlmann","year":"2003","unstructured":"Kuhlmann O, Hofmann H-S, M\u00fcller SP, Weiss M. Pharmacokinetics of idarubicin in the isolated perfused rat lung: effect of cinchonine and rutin. Anticancer Drugs. 2003;14:411\u20136.","journal-title":"Anticancer Drugs"},{"key":"3370_CR57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/jamp.2009.0790","volume":"23","author":"E Selg","year":"2010","unstructured":"Selg E, Acevedo F, Nybom R, Blomgren B, Ryrfeldt \u00c5, Gerde P. Delivering horseradish peroxidase as a respirable powder to the isolated, perfused, and ventilated lung of the rat: the pulmonary disposition of an inhaled model biopharmaceutical. J Aerosol Med Pulm Drug Deliv. 2010;23:273\u201384.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"3370_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0300-483X(81)90013-5","volume":"21","author":"HM Mehendale","year":"1981","unstructured":"Mehendale HM, Angevine LS, Ohmiya Y. The isolated perfused lung \u2014 a critical evaluation. Toxicology. 1981;21:1\u201336.","journal-title":"Toxicology"},{"key":"3370_CR59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2307\/3562892","volume":"21","author":"JL Nelson","year":"1991","unstructured":"Nelson JL, Baird RM, Rosenbaum SE. Suffering, species, and science. Hastings Cent Rep. 1991;21:43\u201343.","journal-title":"Hastings Cent Rep"},{"key":"3370_CR60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1258\/002367794780681714","volume":"28","author":"M Balls","year":"1994","unstructured":"Balls M. Replacement of animal procedures: alternatives in research, education and testing. Lab Anim. 1994;28:193\u2013211.","journal-title":"Lab Anim"},{"key":"3370_CR61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/026119291204000404","volume":"40","author":"M Fischer","year":"2012","unstructured":"Fischer M, Koch W, Windt H, Dasenbrock C. A pilot study on the refinement of acute inhalation toxicity studies: the isolated perfused rat lung as a screening tool for surface-active substances. Altern Lab Anim. 2012;40:199\u2013209.","journal-title":"Altern Lab Anim"},{"key":"3370_CR62","doi-asserted-by":"crossref","first-page":"105648","DOI":"10.1016\/j.yrtph.2024.105648","volume":"150","author":"AO Stucki","year":"2024","unstructured":"Stucki AO, Sauer UG, Allen DG, Kleinstreuer NC, Perron MM, Yozzo KL, et al. Differences in the anatomy and physiology of the human and rat respiratory tracts and impact on toxicological assessments. Regul Toxicol Pharmacol. 2024;150:105648.","journal-title":"Regul Toxicol Pharmacol"},{"key":"3370_CR63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/08941939.2016.1231856","volume":"30","author":"I Christakis","year":"2017","unstructured":"Christakis I, Scott R, Minnion J, Cuenco J, Tan T, Palazzo F, et al. Measuring the pharmacokinetic properties of drugs with a novel surgical rat model. J Investig Surg. 2017;30:162\u20139.","journal-title":"J Investig Surg"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03370-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:49:05Z","timestamp":1780390145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03370-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3370"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03370-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alessandro Fioni is employee of Chiesi Farmaceutici S.p.A. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"120"}}